Odette Wegwarth

Senior Research Scientist Center for Adaptive Rationality

Publications

Contact:
Phone: +49 30 82406-695
E-Mail: wegwarth@mpib-berlin.mpg.de

Short CV:

  • 2015 – Habilitation and Venia legendi in Medical Sociology and Sciences of Rehabilitation, Charité – Universitätsmedizin Berlin
  • 2007 – Dissertation (Dr. rer. nat.) in Psychology, Humboldt Universität zu Berlin
  • 2003 – Diploma (Dipl.-Psych.) in Psychology, University of Potsdam

Scientific Principal

  • Experiencing the risk of overutilizing opioids among patients with non-tumor chronic pain in ambulant care (ERONA), German Federal Ministry of Health (BMG)
  • Female cancer prediction using cervical omics to individualise screening and prevention ( FORECEE) (WP4), European Union’s Horizon 2020 research and innovation programme

Main Focus

  • Medical risk literacy in doctors and patients
  • Evidence-based decision making
  • Fast-and-frugal decision support tools
  • Defensive decision making in medicine
  • Conflict of interests in medicine

Selected Literature:


(exhaustive publication list; see "Publications")

  • Wegwarth, O. & Pashayan, N. (2019). When evidence says no: Gynecologists' reasons for (not) recommending ineffective ovarian cancer screening. BMJ Quality & Safety. Advance online publication.
  • Wegwarth, O., & Gigerenzer, G. (2018). US gynecologists' estimates and beliefs regarding ovarian cancer screening's effectiveness 5 years after release of the PLCO evidence. Scientific Reports, 8:17181.
  • Wegwarth, O., Wagner, G. G., & Gigerenzer, G. (2017). Can facts trump unconditional trust? Evidence-based information halves the influence of physicians' non-evidence-based cancer screening recommendations. PLoS ONE, 12(8):e0183024.
  • Wegwarth, O. (2015). Cancer survival rates: The CONCORD-2 study. The Lancet, 386(9992), 429.
  • Wegwarth, O., & Gigerenzer, G. (2013). Overdiagnosis and overtreatment: Evaluation of what physicians tell patients about screening harms. JAMA Internal Medicine, 173, 2086-2087.
  • Wegwarth, O., Schwartz, L. M., Woloshin, S., et al. (2012). Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Annals of Internal Medicine, 156, 340-349, W-92-W-94.
  • Wegwarth, O., & Gigerenzer, G. (2011). "There is nothing to worry about": Gynecologists' counseling on mammography. Patient Education and Counseling, 84, 251-256.
  • Gigerenzer, G., Wegwarth, O., & Feufel, M. (2010). Misleading communication of risk. British Medical Journal, 341, 791-92.
  • Wegwarth, O., Gaissmaier, W., & Gigerenzer, G. (2009). Smart strategies for doctors and doctors in training: Heuristics in Medicine. Medical Education, 43(8), 721-28.

Honors and Awards:

  • 2019: Invited expert by the Nobel Foundation, the Swedish ambassador Mr. Per Thöresson, and the Leopoldina for the Nobel Prize Dialogues “Towards Health: Equality, Responsibility, and Research,” Panel: Vaccine hesitancy, Berlin.
  • 2019 - : Appointed Experted for the WHO European Technical Consultation on Screening, World Health Organization, UN-City Kopenhagen (DK).
  • 2017: Appointed Expert by the German Chancellery for the 3rd Forum of Germany "Global health and innovation," Berlin (Germany).
  • 2016: Dr. Lothar Beyer Prize, German Society of General and Family Medicine (DEGAM), Frankfurt/Main (Germany).
  • 2013: Early Investigator Award, Society of Behavioral Medicine, San Francisco (USA).
  • 2012: Appointed Expert at the citizen dialogue "Future technologies: High tech medicine, “German Federal Ministry for Education and Research (BMBF), Berlin (Germany).
  • 2010: International Collaboration Grant, Icahn School of Medicine at Mount Sinai, New York City (USA). 
  • 2009: Visiting Fellow Grant, Clinical Epidemiology Interdisciplinary Research Group, Cardiff University (UK).
Go to Editor View